Final analysis of Phase III clinical trials data will be public soon: Bharat Biotech
Hyderabad-based Bharat Biotech on Saturday stated that the scientific standards and commitment of its indigenously manufactured Covid-19 vaccine Covaxin are transparent and emphasized that the company has as of now launched as many as nine research studies on the parameters of its safety and efficacy. In a tweet, co-founder of Bharat Biotech and joint MD,…